CLASS I ONGOING Device recall · Reported 18 Aug 2021 · FDA Enforcement Report

HVAD Outflow Graft recalled by Heartware

Heartware is recalling HeartWare HVAD Outflow Graft, distributed nationwide in the US. The recall was initiated on 3 Jun 2021 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesGTIN: 00888707007627, 00888707007634 All serial numbers
Quantity recalled459 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2196-2021
FDA event ID
88197
Recalling firm
Heartware, Miami Lakes, FL
Classification
Class I
Status
Ongoing
Recall initiated
3 Jun 2021
FDA classified
6 Aug 2021
Reported
18 Aug 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

3 Jun 2021Recall initiated by company
6 Aug 2021Classified by FDA+64 days
18 Aug 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Medtronic is stopping the distribution and sale of the HVAD System due to a growing body of observational clinical comparisons that shows a higher frequency of neurological adverse events and mortality associated with the system when compared to other commercially available left ventricular assist devices, as well as complaints that the internal pump may delay or fail to restart.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

HeartWare HVAD Outflow Graft, REF MCS1725OG

Where it was distributed

Worldwide distribution. US nationwide and Armenia, AUSTRIA, Bahrain, Belgium, CROATIA, CZECH REPUBLIC, Denmark, EGYPT, ESTONIA, FINLAND, FRANCE, GERMANY, GREECE, Hungary, Israel, ITALY, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, LITHUANIA, LUXEMBOURG, Macedonia, NETHERLANDS, Norway, POLAND, Qatar, Romania, SAUDI ARABIA, Serbia, Slovakia, SOUTH AFRICA, Spain, Sweden, SWITZERLAND, TAIWAN, Turkey, Ukraine, UNITED ARAB EMIRATES, and United Kingdom.

Nationwide

Questions about this recall

Is HVAD Outflow Graft recalled?

Yes. Heartware recalled HVAD Outflow Graft on 3 Jun 2021. The recall is Class I and its status is Ongoing. Recall number Z-2196-2021.

Why was it recalled?

Medtronic is stopping the distribution and sale of the HVAD System due to a growing body of observational clinical comparisons that shows a higher frequency of neurological adverse events and mortality associated with the system when compared to other commercially available left ventricular assist devices, as well as complaints that the internal pump may delay or fail to restart.

Which lots are affected?

GTIN: 00888707007627, 00888707007634 All serial numbers

Where was it sold?

Worldwide distribution. US nationwide and Armenia, AUSTRIA, Bahrain, Belgium, CROATIA, CZECH REPUBLIC, Denmark, EGYPT, ESTONIA, FINLAND, FRANCE, GERMANY, GREECE, Hungary, Israel, ITALY, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, LITHUANIA, LUXEMBOURG, Macedonia, NETHERLANDS, Norway, POLAND, Qatar, Romania, SAUDI ARABIA, Serbia, Slovakia, SOUTH AFRICA, Spain, Sweden, SWITZERLAND, TAIWAN, Turkey, Ukraine, UNITED ARAB EMIRATES, and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Heartware

All 69

Other Other Medical Devices recalls

All 13,778